Primary Liver Cancer Risk and Mortality in Patients With Alcohol-Related Cirrhosis in England and Denmark: Observational Cohort Studies.

IF 8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
American Journal of Gastroenterology Pub Date : 2025-03-01 Epub Date: 2024-09-09 DOI:10.14309/ajg.0000000000003077
Morten Daniel Jensen, Joe West, Colin Crooks, Joanne R Morling, Frederik Kraglund, Tim Card, Gro Askgaard, Peter Jepsen
{"title":"Primary Liver Cancer Risk and Mortality in Patients With Alcohol-Related Cirrhosis in England and Denmark: Observational Cohort Studies.","authors":"Morten Daniel Jensen, Joe West, Colin Crooks, Joanne R Morling, Frederik Kraglund, Tim Card, Gro Askgaard, Peter Jepsen","doi":"10.14309/ajg.0000000000003077","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Patients with alcohol-related cirrhosis (ALD cirrhosis) have an increased risk of primary liver cancer (hepatocellular carcinoma [HCC] or intrahepatic cholangiocarcinoma [iCCA]). England recommends surveillance for HCC in these patients, while Denmark does not.</p><p><strong>Methods: </strong>We performed an observational cohort study using the English Clinical Practice Research Datalink and the nationwide Danish healthcare registries to identify 17,110 English (2000-2016) and 22,122 Danish (1994-2022) patients with diagnosis codes of ALD cirrhosis. We computed and compared incidence rates and cumulative incidence of primary liver cancer, annual ultrasound scan rates, and mortality following diagnosis of primary liver cancer.</p><p><strong>Results: </strong>The overall risk of primary liver cancer was similar in England and Denmark: 5-year risk was 2.24% (95% confidence interval 2.00-2.49) in England (iCCA 0.07%, HCC 2.16%) and 2.36% (2.15-2.57) in Denmark (iCCA 0.05%, HCC 2.30%). The annual rate of ultrasound scans per person was 0.65 (0.63-0.67) in England and 0.44 (0.42-0.46) in Denmark. The 1-year mortality after a diagnosis of primary liver cancer was 59.2% (54.4-64.0) in England and 60.9% (57.4-64.4) in Denmark. The 3-year risks of HCC in those on vs off surveillance in England were 2.3% (1.0-4.6) vs 1.5% (1.0-2.2).</p><p><strong>Discussion: </strong>The risk of primary liver cancer was the same in English and Danish patients with ALD cirrhosis, and HCCs constituted 97% of primary liver cancers. Mortality with primary liver cancer was equally high in both countries. Notably, in England, where guidance recommends biannual HCC surveillance with ultrasound, patients with ALD cirrhosis were undergoing fewer than 1 ultrasound scan per year.</p>","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":"593-602"},"PeriodicalIF":8.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14309/ajg.0000000000003077","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Patients with alcohol-related cirrhosis (ALD cirrhosis) have an increased risk of primary liver cancer (hepatocellular carcinoma [HCC] or intrahepatic cholangiocarcinoma [iCCA]). England recommends surveillance for HCC in these patients, while Denmark does not.

Methods: We performed an observational cohort study using the English Clinical Practice Research Datalink and the nationwide Danish healthcare registries to identify 17,110 English (2000-2016) and 22,122 Danish (1994-2022) patients with diagnosis codes of ALD cirrhosis. We computed and compared incidence rates and cumulative incidence of primary liver cancer, annual ultrasound scan rates, and mortality following diagnosis of primary liver cancer.

Results: The overall risk of primary liver cancer was similar in England and Denmark: 5-year risk was 2.24% (95% confidence interval 2.00-2.49) in England (iCCA 0.07%, HCC 2.16%) and 2.36% (2.15-2.57) in Denmark (iCCA 0.05%, HCC 2.30%). The annual rate of ultrasound scans per person was 0.65 (0.63-0.67) in England and 0.44 (0.42-0.46) in Denmark. The 1-year mortality after a diagnosis of primary liver cancer was 59.2% (54.4-64.0) in England and 60.9% (57.4-64.4) in Denmark. The 3-year risks of HCC in those on vs off surveillance in England were 2.3% (1.0-4.6) vs 1.5% (1.0-2.2).

Discussion: The risk of primary liver cancer was the same in English and Danish patients with ALD cirrhosis, and HCCs constituted 97% of primary liver cancers. Mortality with primary liver cancer was equally high in both countries. Notably, in England, where guidance recommends biannual HCC surveillance with ultrasound, patients with ALD cirrhosis were undergoing fewer than 1 ultrasound scan per year.

英格兰和丹麦酒精相关肝硬化患者的原发性肝癌风险和死亡率:观察性队列研究。
背景目的:酒精相关性肝硬化(ALD 肝硬化)患者罹患原发性肝癌(肝细胞癌 [HCC] 或肝内胆管癌 [iCCA])的风险增加。英国建议对这些患者进行 HCC 监测,而丹麦则不建议:我们利用英国临床实践研究数据链(English Clinical Practice Research Datalink)和丹麦全国范围内的医疗保健登记处进行了一项观察性队列研究,以确定 17110 名英国患者(2000-2016 年)和 22122 名丹麦患者(1994-2022 年)的诊断代码为 ALD 肝硬化。我们计算并比较了原发性肝癌的发病率和累积发病率、年度超声波扫描率以及确诊原发性肝癌后的死亡率:结果:英格兰和丹麦的原发性肝癌总体风险相似:英格兰的 5 年风险为 2.24%(95% CI 2.00-2.49)(iCCA 0.07%,HCC 2.16%),丹麦为 2.36%(2.15-2.57)(iCCA 0.05%,HCC 2.30%)。每人每年的超声扫描率在英格兰为 0.65(0.63-0.67)次,在丹麦为 0.44(0.42-0.46)次。原发性肝癌确诊后的1年死亡率,英格兰为59.2%(54.4-64.0),丹麦为60.9%(57.4-64.4)。在英格兰,接受监测与未接受监测者的3年HCC风险分别为2.3%(1.0-4.6)和1.5%(1.0-2.2):结论:英国和丹麦的 ALD 肝硬化患者罹患原发性肝癌的风险相同,HCC 占原发性肝癌的 97%。两国原发性肝癌的死亡率同样很高。值得注意的是,在英国,指南建议每半年用超声波监测一次 HCC,而 ALD 肝硬化患者每年接受的超声波扫描不到一次。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Gastroenterology
American Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
11.40
自引率
5.10%
发文量
458
审稿时长
12 months
期刊介绍: Published on behalf of the American College of Gastroenterology (ACG), The American Journal of Gastroenterology (AJG) stands as the foremost clinical journal in the fields of gastroenterology and hepatology. AJG offers practical and professional support to clinicians addressing the most prevalent gastroenterological disorders in patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信